日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial

copanlisib 联合 nivolumab 治疗 Richter 转化或转化型非霍奇金淋巴瘤患者的安全性和有效性:一项 I 期试验的结果

Shouse, Geoffrey; Chen, Canping; Muir, Alexandra; Popplewell, Leslie; Siddiqi, Tanya; Zain, Jasmine; Herrera, Alex F; Danilova, Olga; Roleder, Carly; Wang, Lili; Spurgeon, Stephen E F; Kittai, Adam S; Chen, Lu; Xia, Zheng; Davids, Matthew S; Danilov, Alexey V

Clarifying comparative evidence on epcoritamab

阐明关于依可利他单抗的比较证据

Danilov, Alexey V

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium

CAR-T方案作为侵袭性B细胞淋巴瘤二线、三线、四线及以上治疗的疗效:来自ABC联盟的真实世界证据

Wang, John S; Ellsworth, Brandon L; Melody, Megan; Epperla, Narendranath; Stephens, Deborah; Romancik, Jason; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Herr, Megan M; Davis, James; Jesme, Christy; Pelcovits, Ari R; Moreira, Jonathan; Lin, Adam Y; Ma, Shuo; Winter, Jane N; Danilov, Alexey V; Shah, Nirav N; Barta, Stefan K; Cohen, Jonathon B; Gordon, Leo I; Grover, Natalie; Karmali, Reem

CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma.

CEACAM1 作为套细胞淋巴瘤中 B 细胞受体信号传导的介质

Xavier Serene, Nguyen Vivian, Khairnar Vishal, Phan An, Yang Lu, Nelson Michael S, Shukla Ravi P, Wang Jinhui, Li Aimin, Geng Huimin, Lee Jaewoong, Sadras Teresa, Pham Lan V, Weisenburger Dennis D, Chan Wing C, Lang Karl S, Shouse Geoffrey P, Danilov Alexey V, Song Joo Y, Parekh Samir, Müschen Markus, Ngo Vu N

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

既往未接受过针对慢性淋巴细胞白血病(CLL)的化疗免疫治疗的里氏转化患者的预后

Kittai, Adam S; Huang, Ying; Miller, Sarah; Allan, John N; Bhat, Seema A; Bond, David A; Brander, Danielle M; Byrd, John C; Chavez, Julio C; Chong, Elise; Davids, Matthew S; Danilov, Alexey V; Ding, Wei; Dowling, Mark R; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J; Ho, Carrie; Hwang, Steven R; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A; Parry, Erin; Rabe, Kari G; Raess, Philipp W; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A; Saha, Aditi; Schade, Jake; Scott, Hamish W; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M; Thompson, Meghan C; Thompson, Philip A; Wang, Yucai; Yano, Max; Woyach, Jennifer A

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

双重打击和双重表达淋巴瘤:CD19靶向CAR T细胞疗法生存结果的多中心分析

Karmali, Reem; Shouse, Geoffrey; Torka, Pallawi; Moyo, Tamara K; Romancik, Jason; Barta, Stefan K; Bhansali, Rahul; Cohen, Jonathon B; Shah, Nirav N; Zurko, Joanna; Kenkre, Vaishalee P; Hess, Brian; Stephens, Deborah M; Fitzgerald, Lindsey; Ollila, Thomas; Tabiti, Bukky; Roy, Ishan; Ma, Shuo; Winter, Jane; Pro, Barbara; Moreira, Jonathan; Danilov, Alexey V; David, Kevin; Gordon, Leo I; Epperla, Narendranath

OmicsTweezer: A distribution-independent cell deconvolution model for multi-omics Data

OmicsTweezer:一种与分布无关的多组学数据细胞反卷积模型

Yang, Xinxing; Zhao, Faming; Ren, Tao; Chen, Canping; Byrne, Katelyn T; Danilov, Alexey V; Sears, Rosalie C; Nelson, Peter S; Coussens, Lisa M; Mills, Gordon B; Xia, Zheng

Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma

阿特珠单抗联合免疫原性挽救性化疗免疫疗法治疗转化型弥漫性大B细胞淋巴瘤患者

Othman, Tamer; Frankel, Paul; Allen, Pamela; Popplewell, Leslie L; Shouse, Geoffrey; Siddiqi, Tanya; Danilov, Alexey V; Ruel, Nora; Daniels, Shari; Peters, Lacolle; Khoo, Stella; Rosen, Steven T; Sharon, Elad; Villalona-Calero, Miguel; Ruel, Christopher; Tuscano, Joseph; Herrera, Alex F

Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial

在SWOG S0016试验中,微小残留病灶状态可预测接受化疗免疫疗法治疗的滤泡性淋巴瘤患者的预后。

Danilov, Alexey V; Li, Hongli; Shadman, Mazyar; Rimsza, Lisa; Zebari, Ahmad; Smith, Sonali M; LeBlanc, Michael; Friedberg, Jonathan W; Carlson, Christopher; Song, Joo Y

Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma

间接比较epcoritamab与化疗免疫疗法、mosunetuzumab或odronextamab在滤泡性淋巴瘤中的疗效

Danilov, Alexey V; Kambhampati Thiruvengadam, Swetha; Linton, Kim; Cumings, Karen; Chirikov, Viktor; Mutebi, Alex; Bains Chawla, Savreet; Chhibber, Anindit; Rivas Navarro, Fernando; Marques Gonçalves, Felipe; Wang, Anthony; Ding, Zhijie; Alshreef, Abualbishr; Favaro, Elena; Hoehn, Daniela; Sureda, Anna